RT Book, Section
A1 Longobardo, Luca
A1 Jain, Renuka
A1 Kramer, Christopher J.
A1 Umland, Matt
A1 Zito, Concetta
A1 Carerj, Scipione
A1 Khandheria, Bijoy K.
A2 Baliga, R. R.
A2 Abraham, William T.
SR Print(0)
ID 1161018693
T1 Role of Echocardiography in Selection, Implantation, and Management of Patients Requiring Left Ventricular Assist Device Therapy
T2 Color Atlas and Synopsis of Heart Failure
YR 2018
FD 2018
PB McGraw-Hill Education
PP New York, NY
SN 9780071749381
LK accesscardiology.mhmedical.com/content.aspx?aid=1161018693
RD 2022/08/12
AB A  66-year-old  man  with  cardiogenic  shock,  severe  left  ventricle  (LV)  systolic  dysfunction,  multiorgan  failure  and  rhabdomyolysis  caused  by  influenza  B  virus  infection  was  admitted  to  the  Intensive  Care  Unit.  He  needed  circulatory  support  with  veno-arterial  extracorporeal  life  support,  intra-aortic  balloon  pump,  inotropes,  and  vasopressors.  In  addition,  mechanical  invasive  ventilation  and  continuous  renal  replacement  therapy  were  needed  to  maintain  respiratory  function,  acid-base  equilibrium,  and  fluid  electrolyte  balance  as  well  as  to  treat  rhabdomyolysis.  Antibiotic  and  antiviral  therapies  were  tailored  by  culture  and  serology.  However,  after  seven  days,  LV  systolic  function  was  not  improved,  the  LV  was  dilating,  and  filling  pressure  was  increasing.  Thus,  the  patient  underwent  left  ventricular  assist  device  (LVAD)  implantation  as  bridging  therapy  to  recovery  or  to  transplantation.  Initially,  the  LVAD  reduced  LV  filling  pressure  and  volume,  and  in  the  following  weeks  LV  systolic  function  slowly  improved.  After  two  months,  LV  systolic  function  recovered  completely,  the  LVAD  was  removed,  and  the  patient  was  transferred  to  a  peripheral  hospital  for  rehabilitation.